Form 4: Cogent Biosciences Director Receives Stock Grant
Insider Transaction (Form 4)
Karen Jean Ferrante, a Director of Cogent Biosciences, Inc., received 759 shares of common stock on October 1, 2026.
Summary
- Grant/award: acquired 759 Stock Option (Right to Buy) on October 1, 2026; holds 759 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Karen Jean Ferrante — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Grant/award | Stock Option (Right to Buy) | 759 | — | — | 759 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Grant/award (759 shares) |
Keywords
insider transaction, Form 4, COGT, Cogent Biosciences, Inc., neutral, Karen Jean Ferrante
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.